Unclaimed brand
Learn all about Novo in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#50A8D8
Shakespeare
80, 168, 216
201, 64, 58
63, 22, 0, 15
#FFFFFF
White
255, 255, 255
0, 0, 100
0, 0, 0, 0
#001965
Midnight Blue
0, 25, 101
225, 100, 20
100, 75, 0, 60
Dicerna Pharmaceuticals, Inc. By harnessing the power of RNA interference, Dicerna aims to silence disease-causing genes. The company focuses on creating safe, effective, and specific RNAi therapies for both rare and common diseases.
Dicerna utilizes its proprietary GalXC™ and GalXC-Plus™ technologies to advance its pipeline of RNAi therapies. These technologies consist of customized double-stranded RNA structures that induce RNAi and are designed to enhance their pharmaceutical properties. The GalXC platform targets the liver, while GalXC-Plus technology extends its reach to other tissues.
Dicerna is committed to improving the lives of patients by providing them with safe and effective medicines. The company aims to alleviate disease-related burdens and restore health by targeting and silencing genes responsible for disease. Dicerna fosters collaboration among employees, patients, physicians, and industry partners to drive scientific advancements and bring transformative therapies to patients.
Join Dicerna in their mission to interfere with disease and create life-changing therapies
Brand industry
Health
Company type
Suggest company type
Year founded
Suggest founded year
Company size
Suggest company size
